Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 180, Issue 1, Pages 187-195
Publisher
Springer Science and Business Media LLC
Online
2020-01-07
DOI
10.1007/s10549-019-05518-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis
- (2018) Olivia L. Tseng et al. Therapeutic Advances in Musculoskeletal Disease
- Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis
- (2016) Song Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
- (2014) Marilyn L. Kwan et al. PLoS One
- Biochemical markers of bone turnover – uses and limitations
- (2014) Thinn Thinn Hlaing et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
- (2013) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- The clinical utility of bone marker measurements in osteoporosis
- (2013) Gillian Wheater et al. Journal of Translational Medicine
- The potential value of monitoring bone turnover markers among women on alendronate
- (2011) Katy JL Bell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- (2011) Eitan Amir et al. JNCI-Journal of the National Cancer Institute
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
- (2010) P. Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
- (2009) M. Rabaglio et al. ANNALS OF ONCOLOGY
- Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years
- (2009) Kaisa K Ivaska et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California
- (2008) Marilyn L. Kwan et al. CANCER CAUSES & CONTROL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More